Navigation Links
Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
Date:10/22/2007

to NSAIDs have been reported in such patients.

Voltaren Gel is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.

Voltaren Gel should not be used in combination with other oral NSAIDs or aspirin because of the potential for increased adverse effects. Similarly, combined use of Voltaren Gel with other topical products, such as sunscreens and cosmetics, on the same skin area has not been tested and should be avoided because of the potential to alter local tolerability and absorption.

Voltaren Gel joins other available Voltaren prescription medications in the US as well as the Novartis global portfolio of Voltaren Emulgel products. For full prescribing information, visit http://www.voltarengel.com or call 1-800-452- 0051.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "will," "often leads to," "may be," "can be," or similar expressions, or by express or implied discussions regarding potential future revenues from Voltaren Gel. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Voltaren Gel will achieve any particular levels of revenue in the future. In particular, management's expectations regarding commercialization of Voltaren Gel could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data, competition in general, increased government, industry and general public pricing pressures, unexpected regulatory actions or delays or government regulat
'/>"/>

SOURCE Novartis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015 Grafika is pleased to announce ... Impressions. , “We’re excited about the acquisition ... capabilities and knowledgeable team members,” according to Bernard Elzer, ... to offer an ever wider breadth of products to ... specialty services we already offer. It also complements ...
(Date:4/21/2015)... April 21, 2015 “ ZeroWire ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... how ZeroWire is a security system and lifestyle management ... there were over 2 million burglaries in 2010. It ...
(Date:4/21/2015)... April 21, 2015 The ... provides comparative analysis on the therapeutic development ... by identifying new targets and MOAs to ... with TOC is available @ http://www.rnrmarketresearch.com/sinusitis-pipeline-review-h1-2015-market-report.html ... key players involved in the therapeutic development ...
(Date:4/21/2015)... 2015 AvePoint, the established ... today announced a new enhancement to DocAve Policy ... Office 365 Management Activity API. This integration creates a ... and take action on all events that take place ... 365 Management Activity API provides customers with greater transparency ...
(Date:4/21/2015)... April 21, 2015 Catalent (Booth ... technologies and development solutions for drugs, biologics and ... ADVASEPT™ Lock, a stopper-less, glass- and needle-free vial ... medications. Easily opened, ADVASEPT Lock attaches to a ... container closure with the security of an advanced ...
Breaking Medicine News(10 mins):Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2
... COLUMBIA, Mo. Osteoarthritis is commonly diagnosed in the ... expected to decrease pain and slow progression of disease. ... and humans, doctors and veterinarians need a precise way ... of Missouri researchers are investigating potential biomarkers in dogs ...
... , -- New Tissue Dissection System Used by Italian Surgeons ... , PALO ALTO, Calif., June 10 PEAK Surgical, ... System by surgeons in the European Union, where the innovative ... , , Dr. Raul Pellini and Prof. Giuseppe Spriano, ...
... in U.S. Senate & House will help eliminate barriers ... , WASHINGTON, June 10 Late yesterday U.S. ... legislation that will improve access to life-saving diagnostic tests ... Access to Critical Lab Tests Act (S. 1220) will ...
... partners with Canadian Hospital Specialties, to release EchoStim(R) ... , CINCINNATI, June 10 Havel,s Incorporated, ... partnered with CHS, Canadian Hospital Specialties, which will ... EchoBlock(R) Ultrasound Needles throughout Canada. , , ...
... Would Increase Threat of Disease , , PHILADELPHIA, June 10 ... John Hanger today asked Pennsylvanians to make every effort to control ... , Hanger said standing water can quickly become a breeding ... rule of dump it, drain it and treat it. , ...
... June 10 Millennium Research Group (MRG), the global ... the economic downturn, market growth in the European gastrointestinal ... cancer (CRC) screening programs in France, Germany, and the ... European Markets for GI Endoscopy Devices 2009 report, ...
Cached Medicine News:Health News:Early detection of osteoarthritis in dogs could open doors for a cure 2Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 2Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 3Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 4Health News:Legislation Will Expand Access to Life-Saving Laboratory Tests 2Health News:Havel's Incorporated Expands Successful EchoStim(R) Ultrasound Needles into Canada 2Health News:DEP Asks Pennsylvanians to Help Battle West Nile Virus 2Health News:DEP Asks Pennsylvanians to Help Battle West Nile Virus 3Health News:Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group 2Health News:Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group 3
(Date:4/21/2015)... The North American dermatology diagnostic devices market ... from 2014 to 2019. Although mature markets (the U.S. ... in the dermatology diagnostic devices market, Mexico ... CAGR of 9.8% during the forecast period. The growth ... factors such as rising incidences of skin disorders, increasing ...
(Date:4/21/2015)... Fla. , April 21, 2015   Rock ... drug development company focused on the treatment of chronic ... key independent appointment to the Company,s Board of Directors ... Samuel as a new director. ... of Rock Creek Pharmaceuticals, said, "Dr. Samuel,s experience in ...
(Date:4/21/2015)... -- This report analyzes the worldwide markets for Apheresis ... for Therapeutic Apheresis, and Equipment for Donor Apheresis. Global ... Plateletpheresis, and Others. The report provides separate comprehensive analytics ... Japan , Europe , ... Annual estimates and forecasts are provided for the period ...
Breaking Medicine Technology:North American Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019 2North American Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 2Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 4Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 5Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 6Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 7World Apheresis Equipment Industry 2World Apheresis Equipment Industry 3World Apheresis Equipment Industry 4World Apheresis Equipment Industry 5World Apheresis Equipment Industry 6World Apheresis Equipment Industry 7World Apheresis Equipment Industry 8World Apheresis Equipment Industry 9World Apheresis Equipment Industry 10World Apheresis Equipment Industry 11World Apheresis Equipment Industry 12World Apheresis Equipment Industry 13World Apheresis Equipment Industry 14World Apheresis Equipment Industry 15World Apheresis Equipment Industry 16World Apheresis Equipment Industry 17World Apheresis Equipment Industry 18World Apheresis Equipment Industry 19World Apheresis Equipment Industry 20World Apheresis Equipment Industry 21
... Aug. 2 RoundTable Healthcare Partners ("RoundTable"), ... healthcare industry, announced today that its portfolio company, Aspen ... Bard-Parker ™ surgical blades and scalpels ... a leading manufacturer of disposable medical products with an ...
... SAN DIEGO , Aug. 2 Novalar Pharmaceuticals, Inc., a ... premier pharmaceutical product, has again been selected by leading dental industry magazine ... full results of the 24th annual competition were published in the July ... ...
Cached Medicine Technology:RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parker™ Surgical Blades and Scalpels Business 2RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parker™ Surgical Blades and Scalpels Business 3OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 2OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: